- Home
- ANVS vs SCNX Comparison
ANVS vs SCNX Comparison
Compare ANVS & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANVS
- SCNX
- Stock Information
- Founded
- ANVS 2008
- SCNX 2010
- Country
- ANVS United States
- SCNX United States
- Employees
- ANVS N/A
- SCNX N/A
- Industry
- ANVS Biotechnology: Pharmaceutical Preparations
- SCNX Other Pharmaceuticals
- Sector
- ANVS Health Care
- SCNX Health Care
- Exchange
- ANVS Nasdaq
- SCNX Nasdaq
- Market Cap
- ANVS 31.2M
- SCNX 33.6M
- IPO Year
- ANVS 2020
- SCNX 2020
- Fundamental
- Price
- ANVS $1.48
- SCNX $1.34
- Analyst Decision
- ANVS Strong Buy
- SCNX
- Analyst Count
- ANVS 5
- SCNX 0
- Target Price
- ANVS $37.00
- SCNX N/A
- AVG Volume (30 Days)
- ANVS 257.8K
- SCNX 8.6M
- Earning Date
- ANVS 05-12-2025
- SCNX 05-10-2025
- Dividend Yield
- ANVS N/A
- SCNX N/A
- EPS Growth
- ANVS N/A
- SCNX N/A
- EPS
- ANVS N/A
- SCNX 2.68
- Revenue
- ANVS N/A
- SCNX $136,643.00
- Revenue This Year
- ANVS N/A
- SCNX $1,085.75
- Revenue Next Year
- ANVS N/A
- SCNX N/A
- P/E Ratio
- ANVS N/A
- SCNX $1.99
- Revenue Growth
- ANVS N/A
- SCNX N/A
- 52 Week Low
- ANVS $1.43
- SCNX $1.00
- 52 Week High
- ANVS $20.00
- SCNX $23.77
- Technical
- Relative Strength Index (RSI)
- ANVS 30.83
- SCNX N/A
- Support Level
- ANVS $1.43
- SCNX N/A
- Resistance Level
- ANVS $2.07
- SCNX N/A
- Average True Range (ATR)
- ANVS 0.14
- SCNX 0.00
- MACD
- ANVS 0.04
- SCNX 0.00
- Stochastic Oscillator
- ANVS 7.03
- SCNX 0.00
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.